6141. Travel Medicine.
International travel can result in new illness or exacerbate existing conditions, and primary care clinicians have the opportunity to provide both pre- and posttravel health care. Providers should be familiar with destination-specific disease risks, be knowledgeable about travel and routine vaccines, be prepared to prescribe chemoprophylaxis and self-treatment regimens, and be aware of travel medicine resources.
6151. Extracranial Carotid Disease and Effect of Intra-arterial Treatment in Patients With Proximal Anterior Circulation Stroke.
作者: Volker Maus.;Nuran Abdullayev.;Marios Nikos Psychogios.;Daniel Behme.;Anastasios Mpotsaris.
来源: Ann Intern Med. 2018年168卷1期83页 6153. Use of Immune Checkpoint Inhibitors in the Treatment of Patients With Cancer and Preexisting Autoimmune Disease: A Systematic Review.
作者: Noha Abdel-Wahab.;Mohsin Shah.;Maria A Lopez-Olivo.;Maria E Suarez-Almazor.
来源: Ann Intern Med. 2018年168卷2期121-130页
Cancer immunotherapy with checkpoint inhibitors (CPIs) is associated with frequent immune-related adverse events (irAEs) and is often not recommended for patients with concomitant autoimmune disease.
6154. Preventing Lung Cancer Mortality by Computed Tomography Screening: The Effect of Risk-Based Versus U.S. Preventive Services Task Force Eligibility Criteria, 2005-2015.
作者: Li C Cheung.;Hormuzd A Katki.;Anil K Chaturvedi.;Ahmedin Jemal.;Christine D Berg.
来源: Ann Intern Med. 2018年168卷3期229-232页 6157. Risk-Targeted Lung Cancer Screening: A Cost-Effectiveness Analysis.
作者: Vaibhav Kumar.;Joshua T Cohen.;David van Klaveren.;Djøra I Soeteman.;John B Wong.;Peter J Neumann.;David M Kent.
来源: Ann Intern Med. 2018年168卷3期161-169页
Targeting low-dose computed tomography (LDCT) for lung cancer screening to persons at highest risk for lung cancer mortality has been suggested to improve screening efficiency.
6158. Comparison of Five Major Guidelines for Statin Use in Primary Prevention in a Contemporary General Population.
Five major organizations recently published guidelines for using statins to prevent atherosclerotic cardiovascular disease (ASCVD): in 2013, the American College of Cardiology/American Heart Association (ACC/AHA); in 2014, the United Kingdom's National Institute for Health and Care Excellence (NICE); and in 2016, the Canadian Cardiovascular Society (CCS), the U.S. Preventive Services Task Force (USPSTF), and the European Society of Cardiology/European Atherosclerosis Society (ESC/EAS).
|